Matthew Geller
Matthew Geller
looks positive wet
(The wet AMD market) is already pretty big. There are treatments, but this looks like a positive step.
dollar
It could be huge, ... potentially a multi-billion dollar drug.
concerned
My first take on it was that I was concerned about dilution to Amgen,
charge develop order orphan price
If you're going to develop an orphan drug, you're going to have to charge a substantial price for the drug in order to make it worthwhile.